ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Storytel Ab (publ)

Storytel Ab (publ) (0GBU)

104.80
0.00
(0.00%)
Closed 05 January 3:30AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
104.80
Bid
99.80
Offer
109.80
Volume
80
0.00 Day's Range 0.00
104.80 52 Week Range 104.80
Market Cap
Previous Close
104.80
Open
-
Last Trade
80
@
66.55
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
444
Shares Outstanding
77,107,000
Dividend Yield
-
PE Ratio
-0.53
Earnings Per Share (EPS)
-10.62
Revenue
3.49B
Net Profit
-819.19M

About Storytel Ab (publ)

Sector
Offices-holdng Companies,nec
Industry
Plumb,heat & Air-condition
Headquarters
Stockholm, Swe
Founded
2009
Storytel Ab (publ) is listed in the Offices-holdng Companies sector of the London Stock Exchange with ticker 0GBU. The last closing price for Storytel Ab (publ) was SEK104.80. Over the last year, Storytel Ab (publ) shares have traded in a share price range of SEK 104.80 to SEK 104.80.

Storytel Ab (publ) currently has 77,107,000 shares in issue. The market capitalisation of Storytel Ab (publ) is SEK8.08 billion. Storytel Ab (publ) has a price to earnings ratio (PE ratio) of -0.53.

0GBU Latest News

Storytel enters strategic partnership with ElevenLabs and announces upcoming launch of new VoiceSwitcher feature

Storytel enters strategic partnership with ElevenLabs and announces upcoming launch of new VoiceSwitcher feature PR Newswire STOCKHOLM, June 13, 2023 STOCKHOLM, June 13, 2023 /PRNewswire/...

Storytel enters strategic partnership with ElevenLabs and announces upcoming launch of new VoiceSwitcher feature

Storytel enters strategic partnership with ElevenLabs and announces upcoming launch of new VoiceSwitcher feature PR Newswire STOCKHOLM, June 13, 2023 STOCKHOLM, June 13, 2023 /PRNewswire/...

Storytel presents mid-term financial targets and strategic direction to further strengthen its leading position

Storytel presents mid-term financial targets and strategic direction to further strengthen its leading position PR Newswire STOCKHOLM, June 13, 2023 STOCKHOLM, June 13, 2023 /PRNewswire/ -- At...

Storytel presents mid-term financial targets and strategic direction to further strengthen its leading position

Storytel presents mid-term financial targets and strategic direction to further strengthen its leading position PR Newswire STOCKHOLM, June 13, 2023 STOCKHOLM, June 13, 2023 /PRNewswire/ -- At...

Invitation to Storytel's Capital Markets Day 2023

Invitation to Storytel's Capital Markets Day 2023 PR Newswire STOCKHOLM, May 22, 2023 STOCKHOLM, May 22, 2023 /PRNewswire/ -- Storytel has the pleasure to invite investors, analysts and media to...

Storytel Group acquires the rights to the Finnish bestselling Koskinen crime series

Storytel Group acquires the rights to the Finnish bestselling Koskinen crime series PR Newswire STOCKHOLM, May 15, 2023 STOCKHOLM, May 15, 2023 /PRNewswire/ -- The Koskinen Crime series is a huge...

Storytel Interim Report January - March 2023

Storytel Interim Report January - March 2023 PR Newswire STOCKHOLM, May 3, 2023 STOCKHOLM, May 3, 2023 /PRNewswire/ -- "Laying the foundation for further profitable growth in 2023 and beyond...

New partnership with A1 Bulgaria brings Storytel's offering to 3.8 million Bulgarians

New partnership with A1 Bulgaria brings Storytel's offering to 3.8 million Bulgarians PR Newswire STOCKHOLM, April 25, 2023 STOCKHOLM, April 25, 2023 /PRNewswire/ -- Storytel, one of the world's...

Storytel and B-Reel shortlisted for the One Show and the Webby Awards

Storytel and B-Reel shortlisted for the One Show and the Webby Awards PR Newswire STOCKHOLM, April 14, 2023 STOCKHOLM, April 14, 2023 /PRNewswire/ -- The captivating Storytel campaign "2022...

Storytel and B-Reel shortlisted for the One Show and the Webby Awards

Storytel and B-Reel shortlisted for the One Show and the Webby Awards PR Newswire STOCKHOLM, April 14, 2023 STOCKHOLM, April 14, 2023 /PRNewswire/ -- The captivating Storytel campaign "2022...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
100104.8104.8104.800DE
400104.8104.8104.8466104.8DE
1200104.8104.8104.8444104.8DE
2600104.8104.8104.82279104.8DE
5200104.8104.8104.81836104.8DE
15600104.8104.8104.812227104.8DE
26000104.8104.8104.87787104.8DE

0GBU - Frequently Asked Questions (FAQ)

What is the current Storytel Ab (publ) share price?
The current share price of Storytel Ab (publ) is SEK 104.80
How many Storytel Ab (publ) shares are in issue?
Storytel Ab (publ) has 77,107,000 shares in issue
What is the market cap of Storytel Ab (publ)?
The market capitalisation of Storytel Ab (publ) is SEK 8.08B
What is the 1 year trading range for Storytel Ab (publ) share price?
Storytel Ab (publ) has traded in the range of SEK 104.80 to SEK 104.80 during the past year
What is the PE ratio of Storytel Ab (publ)?
The price to earnings ratio of Storytel Ab (publ) is -0.53
What is the cash to sales ratio of Storytel Ab (publ)?
The cash to sales ratio of Storytel Ab (publ) is 0.13
What is the reporting currency for Storytel Ab (publ)?
Storytel Ab (publ) reports financial results in SEK
What is the latest annual turnover for Storytel Ab (publ)?
The latest annual turnover of Storytel Ab (publ) is SEK 3.49B
What is the latest annual profit for Storytel Ab (publ)?
The latest annual profit of Storytel Ab (publ) is SEK -819.19M
What is the registered address of Storytel Ab (publ)?
The registered address for Storytel Ab (publ) is TRYCKERIGATAN 4, STOCKHOLM, SE-104 51
What is the Storytel Ab (publ) website address?
The website address for Storytel Ab (publ) is www.massolitmedia.se
Which industry sector does Storytel Ab (publ) operate in?
Storytel Ab (publ) operates in the PLUMB,HEAT & AIR-CONDITION sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M

Discussion

View Full Feed
axelvento axelvento 13 minutes ago
Q1 the first interim analysis of the vaccine’s efficacy is expected

Moderna’s mRNA-1647
Cytomegalovirus
MRNA
MightyX MightyX 16 minutes ago
Yet no one is innocent
TPTW
BIG D 4 BIG D 4 16 minutes ago
WOW !! HAPPY NEW YEAR TO ALL THE LONGS HERE !! I HAVE 2 NAYSAYERS ON IGNORE SO I NEVER READ THEIR BS !! GO SAVING GRACE-- JJ AND ALL THE NEW POSTERS WHO ARE POSITIVE !! .02 CENTS TO START THE RUN TO ONE DOLLAR IS WHERE WE SHOULD BE !! THIS STOCK IS SUCH A GREAT BUY HERE !! I AM LOADED WITH 32 MILLI
MJNA
MightyX MightyX 17 minutes ago
The judicial system legitimizes prosecution
TPTW
jondoeuk jondoeuk 18 minutes ago
A new paper. From it: 'BNT221 was well tolerated across both DLs, with no dose-limiting toxicities of grade 3 or higher attributed to the T cell product observed. Specifically, no cytokine release, immune effector cell-associated neurotoxicity or macrophage activation syndromes were reported. A dose
BNTX
benz280c benz280c 19 minutes ago
Nice to see you are bullish. This quote may round out your knowledge.
"It is worthy to note that a new CUSIP has been approved by the CUSIP Global Services (CGS).
Subsequently, we have submitted a corporation action with FINRA for a Company name change, Ticker Symbol Change and Cusip
GDVM
shajandr shajandr 20 minutes ago
Sorry to read that you're still feeling sick. I posted a week or two ago about 41 bunnies and also some cats and dogs that were rescued from a home in Delaware county, Iowa and that were transferred to the DBQ county animal shelter. I just spoke with DaSqu_w and she went to the animal shelter to see
Lakota-45 Lakota-45 21 minutes ago
Will do, but I doubt they will listen !!!

~ Lol !!!
IONI
boi568 boi568 22 minutes ago
Probably
AVXL
HokieHead HokieHead 24 minutes ago
Wrong..
TWOH
HokieHead HokieHead 24 minutes ago
Get your facts straight, the halt was in the Canadian side as they are reviewing all the disclosures submitted, there’s ZERO issues in the US, it’s a fully reporting SEC company.
TWOH
Lakota-45 Lakota-45 26 minutes ago
I agree with you 'farmI1234 !!!

I'm pretty sure most of the Savvy Investors, that have been paying attention,
have been loading the dips, and .0004's, for a while now.
I know I have, along with fishing down stream.

I doubt any Longs will get caught short,
WDLF
CaptHowdy CaptHowdy 27 minutes ago
RECOMMENDED.... nothing is offical yet, unnecessary twisting of facts to bolster your negative viewpoints. Thats news is two months old
GRLT
axelvento axelvento 28 minutes ago
Cancer vaccines: What’s ahead in 2025

The spotlight is on mRNA-4157 (V940)

https://gulfnews.com/special-reports/cancer-vaccines-whats-ahead-in-2025-1.500010233
MRNA
facts_matter14 facts_matter14 29 minutes ago
Does this sound like a company with 16 products and a 17th on the way?

https://investorshub.advfn.com/uimage/uploads/2024/12/24/mwowsIMG_6034.png








.
SRMX
HomerRomer HomerRomer 29 minutes ago
More testimony videos from trial participants like the Australian news reel of Ern Heaven would be amazing. I would think that most of the people involved 9 years ago in the earlier phase studies have passed on since the average life expectancy is normally between 3-11 years after being diagnosed w
AVXL
CaptHowdy CaptHowdy 30 minutes ago
That's how to make money on the OTC. 🤦🏻‍♂️ Anyone could do it; only if the effort spent discounting the new leadership in place along with the turn around story underway was used to turn a profit vs. using 9yr old DD to bad mouth new CEO.
GRLT
crescentmotor crescentmotor 31 minutes ago
I think that is a bad precedent to start.

100% on parading a handful of Blarcamesine patients at the JPM conference. I highly doubt AVXL would involve itself with anecdotal gimmicks where there is no way possible to extrapolate isolated successes to meaningful conclusions about broad
AVXL JPM
Steady_T Steady_T 33 minutes ago
MABS are the current standard of care, so Blarcamesine has to be better than the MABS, which is not saying much.

I suspect that if Blarcamesine was the equal of the MABS is would still be approved on safety and cost grounds.

As has been pointed out multiple times on the
AVXL
facts_matter14 facts_matter14 34 minutes ago
Looks like Baggy is worried about Maxine not showing up at CES this week…………….









.
SRMX
Bourbon_on_my_cornflakes Bourbon_on_my_cornflakes 35 minutes ago
Anavex has delayed PD in order to wait out the development of a reliable biomarker, which has happened only during the past few months.

OK so we should see the test start this quarter then?
AVXL
Canna_Business Canna_Business 35 minutes ago
$FKINX $IONQ $FFALX $MRMD $RKLB $XOM $DUK $LNVGY $V $SOFI $BICEY $VOO $TEMWX
BICEY DUK FFALX
mrfence mrfence 35 minutes ago
Actually, these issues traded on the NYSE under conservatorship and the FHFA made a decision to voluntarily delist Fannie and Freddie from the NYSE. There's Companies in bankruptcy like Gamestop, GME, trading on Big Boards. Unfortunately, the ball's in Gooberment's as to when they see fit to up lis
GME
Canna_Business Canna_Business 35 minutes ago
$FKINX $IONQ $FFALX $MRMD $RKLB $XOM $DUK $LNVGY $V $SOFI $BICEY $VOO $TEMWX
BICEY DUK FFALX

Your Recent History

Delayed Upgrade Clock